Athersys And To Collaborate On MultiStem Commercial Manufacturing In Japan

Athersys’ collaborator, HEALIOS K.K. (Healios), has an exclusive license to develop and market MultiStem in Japan for ischemic stroke … our ability to protect our intellectual property portfolio; our possible inability to execute our strategy due …
( read original story …)


Related Post

Tokyo a busier real estate market than New York an...
views 30
Property investment volumes in Tokyo stood at USD9...
Traders listening for signals from Bank of Japan
views 175
Stocks will likely continue their drift higher Tue...
Editorial: Japan and the world’s animal spirits st...
views 9
Mercari’s initial public offering (IPO) is set to ...
Simon Property Group (SPG) Q2 2017 Results –...
views 159
for each and every year in Japan. So, we look at i...
Japanese bank Daiwa 'finalising plans for mov...
views 285
Japanese investment bank Daiwa is understood to be...
Bird flu outbreak hits zoo events linked to Year o...
views 171
TOKYO - The recent outbreak of a highly virulent s...
The Bank of Japan leaves policy unchanged
views 240
YOKOHAMA, JAPAN – JUNE 11: Shinji Okazaki #9 of Ja...
Workaholic Japan 'Names And Shames' Firm...
views 176
Tokyo: Japan has released its first nationwide emp...
Nothing cold about sub-zero rates, IMF researchers...
views 134
Japan, Sweden and Switzerland. Cutting rates below...
Japan business mood brightens as yen weakens: Reut...
views 202
TOKYO Japanese manufacturers' confidence rose for ...